Robert O. Kerr

The Impact of Age on Delivered Dose Intensity and Hospitalizations for Febrile Neutropenia in Patients with Intermediate-Grade Non-Hodgkin's Lymphoma Receiving Initial CHOP Chemotherapy: A Risk Factor Analysis

Vicki A. Morrison, Vincent J. Picozzi, Brad Pohlman et al. · Clinical Lymphoma · 2001 · 144 citations

Lymphoid Neoplasia, Intermediate-grade Non-hodgkin, Medicine +8

High-Dose Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: High Rates of Rapid Cytogenetic and Molecular Responses

Jörge E. Cortes, Hagop M. Kantarjian, Stuart L. Goldberg et al. · Journal of Clinical Oncology · 2009 · 125 citations · Full text

Phase II Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients with Advanced Pancreatic Cancer

Muhammad Wasif Saif, Nikolai A. Podoltsev, Mark S. Rubin et al. · Cancer Investigation · 2009 · 88 citations

Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain

Alan Broomhead, Robert O. Kerr, William Tester et al. · Journal of Pain and Symptom Management · 1997 · 82 citations · Full text

Pain Therapy, Oncology, Health Sciences +10

Retreatment with bortezomib alone or in combination for patients with multiple myeloma following an initial response to bortezomib

Raman Sood, Harry Carloss, Robert O. Kerr et al. · American Journal of Hematology · 2009 · 51 citations · Full text